Currently out of the existing stock ratings of Esther Hong, 12 are a BUY (66.67%), 6 are a HOLD (33.33%).

Esther Hong

Work Performance Price Targets & Ratings Chart

Analyst Esther Hong, employed carries an average stock price target met ratio of 33.33% that have a potential upside of 21.65% achieved within 134 days on average. Previously, Esther Hong worked at BERENBERG.

Esther Hong’s has documented 33 price targets and ratings displayed on 7 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on BNOX, Bionomics Ltd ADR at 09-Mar-2023.

Wall Street Analyst Esther Hong

Analyst best performing recommendations are on CMPS (COMPASS PATHWAYS PLC).
The best stock recommendation documented was for CMPS (COMPASS PATHWAYS PLC) at 10/13/2020. The price target of $50 was fulfilled within 51 days with a profit of $11.18 (28.8%) receiving and performance score of 5.65.

Average potential price target upside

ALDX Aldeyra The CNCE Concert Pharmaceuticals SPRO Spero Therapeutics ACAD ACADIA Pharmaceuticals AXSM Axsome Therapeutics BNOX Bionomics Ltd ADR CMPS Compass Pathways Plc

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

10

$6.27 (168.10%)

10

1 months 11 days ago

0/7 (0%)

$5.88 (142.72%)

Buy

8

$4.27 (114.48%)

25

8 months ago

0/10 (0%)

$6.16 (334.78%)

Hold

14

8 months ago

2/3 (66.67%)

$6.42 (84.70%)

362

Buy

2 years 5 months 21 days ago

0/1 (0%)

$9.48 (75.72%)

Buy

20

$16.27 (436.19%)

20

4 years 11 months 22 days ago

0/4 (0%)

$13.77 (221.03%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Esther Hong?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?